Much promise, scant evidence for multicancer early detection tests

This news section is written by a medical journalist and offers Cancer Cytopathology readers timely information on events, issues, and personalities of interest to the subspecialty. In this first of a two‐part series on new blood‐based cancer tests, direct‐to‐consumer pitches for multicancer detection have far outpaced evidence of real‐world benefits.